Relationship Factors and Engagement in HIV Care in Malawi: A Dyadic Investigation
HIV/AIDS , Engagement in Care
2/5/16
1/31/20
HIV testing and HIV surveillance
HIV/AIDS , Epidemiology and Surveillance
6/28/18
6/28/18
Blood Donation and HIV Prevention in China
Vincanne Adams, PhD
HIV/AIDS
3/15/05
2/28/09
Mentorship for Dissertation: Resistant to Treatment: Medicine, Molecules, and the Global Politics of Drug-Resistant HIV
Vincanne Adams, PhD
HIV/AIDS
2/15/05
1/31/06
Recombinant Picornaviruses as AIDS Vaccines
Raul Andino-Pavlovsky, PhD
HIV/AIDS
9/15/02
2/28/07
Vaccine to Prevent HIV Infection in Pregnancy and Newborns
Raul Andino-Pavlovsky, PhD
HIV/AIDS , Drug and Diagnostics Development , Newborn and Infant Health
9/1/02
8/31/04
ACTG: AIDS Clinical Trials Group
Francesca Aweeka, PharmD
HIV/AIDS , Opportunistic Infection
1/1/14
11/30/20
Pediatric AIDS Clinical Trial Group (PACTG) Pharmacology Support Laboratories
Francesca Aweeka, PharmD
HIV/AIDS
3/1/05
2/28/07
IMPAACT: International Maternal Pediatrics Adolescent AIDS Clinic
Francesca Aweeka, PharmD
HIV/AIDS , Women's Health , Pediatrics
3/16/11
5/31/11
LOC-IMPAACT Leadership Group
Francesca Aweeka, PharmD
HIV/AIDS , Tuberculosis , Drug and Diagnostics Development , Pharmacology and Drug Treatment , Women's Health , Pediatrics , Newborn and Infant Health , Systematic Reviews and Guideline Development
12/1/15
11/30/16
Optimizing ACT use for African children in the setting of HIV and malnutrition
Francesca Aweeka, PharmD
HIV/AIDS , Malaria , Malnutrition, Micronutrients, Food Insecurity
9/13/16
8/31/21
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory
Francesca Aweeka, PharmD
HIV/AIDS
6/29/06
5/31/12
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award
Francesca Aweeka, PharmD
HIV/AIDS , Pediatrics
6/1/12
12/31/13
T003: International Maternal Pediatric Adolescent AIDS Clinical Trials Group IMPAACT
Francesca Aweeka, PharmD
HIV/AIDS , Women's Health , Pediatrics
7/1/06
5/31/10
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda
Francesca Aweeka, PharmD
HIV/AIDS , Malaria , Women's Health , Pediatrics
12/23/10
11/30/16
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)
Francesca Aweeka, PharmD
HIV/AIDS , Tuberculosis , Malaria , Women's Health , Pediatrics , Adolescent Health
6/29/06
5/31/12
Pharmacokinetic analysis of dihydroartemisinin-piperaquine alongside the START-IPT Study
Francesca Aweeka, PharmD
HIV/AIDS , Malaria , Pediatrics
6/1/14
8/31/15
International Maternal Pediatrics Adolescent AIDS Clinic (IMPAACT)
Francesca Aweeka, PharmD
HIV/AIDS , Malaria , Women's Health , Pediatrics
6/1/11
5/31/12
AIDS Clinical Trials Group Network
Francesca Aweeka, PharmD
HIV/AIDS
6/1/12
12/31/13
Testing Sponsor's Antiretroviral Enzyme Immunoassay Method
Francesca Aweeka, PharmD
HIV/AIDS
8/22/07
12/31/10
2.1 Project Title ACTG: AIDS Clinical Trials Group
Francesca Aweeka, PharmD
Infectious Disease , HIV/AIDS , Tuberculosis
1/1/14
11/30/16
Adult AIDS Clinical Trials Group (AACTG): Pharmacology Support Laboratory
Francesca Aweeka, PharmD
HIV/AIDS
4/1/04
8/15/06
ACTG: AIDS Clinical Trials Group; MASTER SUBCONTRACT -- U01AI068636
Francesca Aweeka, PharmD
HIV/AIDS
7/1/06
5/31/13
DDI study between HIV drugs (Efavirenz) and Coartem
Francesca Aweeka, PharmD
HIV/AIDS
5/15/08
12/31/11
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum
Opportunistic Infection
7/1/14
12/31/15
HIV/STD Prevention Among Angolan Military
HIV/AIDS , Risk Reduction and Prevention , Patient and Peer Education
10/1/01
8/31/06
Leadership Group for the Adolescent Medicine Trials Network
HIV/AIDS , Adolescent Health
9/1/03
2/28/06
An Innovative HIV Prevention Curriculum for Medical Students of the University of Puerto Rico Medical School: Implementation and Evaluation Phase
HIV/AIDS , Health Systems Strengthening , Training and Capacity Building , Training International Scholars and Clinicians
9/26/14
9/25/15
Adolescent Medicine Trials Network for HIV/AIDS
HIV/AIDS , Adolescent Health
3/1/06
2/28/11
Technical and Logistical Support for the Office of AIDS Research
HIV/AIDS
7/1/10
3/27/13
Understanding mobility and sexual mixing in SEARCH communities
Carol Camlin, PhD
HIV/AIDS , Epidemiology and Surveillance , Risk Reduction and Prevention , Patient and Peer Education
6/1/15
5/31/20
Identifying Opportunities for HIV Prevention among Female Migrants in Kenya
Carol Camlin, PhD
HIV/AIDS , Women's Health , Immigration and Migration , Risk Reduction and Prevention
2/15/11
12/31/15
CareConekta: Mobile health for a mobile population
Carol Camlin, PhD
HIV/AIDS , Adolescent Health , Engagement in Care , Treatment Adherence , Risk Reduction and Prevention
5/10/19
3/31/21
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients
Adithya Cattamanchi, MD
HIV/AIDS , Tuberculosis , Drug and Diagnostics Development
4/1/09
3/31/15
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129
Henry Chambers, MD
Infectious Disease , Sexually Transmitted Infections (STIs) , Zoonosis, Emerging Disease, and Drug Resistance , HIV/AIDS , Epidemiology and Surveillance
9/1/07
8/31/09
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA)
Henry Chambers, MD
Infectious Disease , Zoonosis, Emerging Disease, and Drug Resistance , Opportunistic Infection
7/27/07
12/31/15
Prevention Umbrella for MSM in the Americas
Henry Chambers, MD
HIV/AIDS , Risk Reduction and Prevention
7/1/11
3/31/12
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus
Henry Chambers, MD
Opportunistic Infection
7/1/02
12/31/04
Epidemiologic Analysis of Data from Project Aware to Determine the Impact of Different HIV Testing Strategies on Risk Behaviors and STD Rates among HIV-Uninfected MSM
Henry Chambers, MD
HIV/AIDS
7/1/11
6/30/12
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections
Henry Chambers, MD
HIV/AIDS , Opportunistic Infection
6/4/09
1/1/12
Prevention Umbrella for MSM in the Americas
Henry Chambers, MD
HIV/AIDS
4/1/12
1/5/14
Leveraging social and sexual networks to reach young men with HIV testing and linkage services
Gabriel Chamie, MD
HIV/AIDS , Health Economics and Effectiveness , Engagement in Care , Treatment Adherence
10/16/18
8/10/20
Innovative incentive strategies for sustainable HIV testing and linkage to care
Gabriel Chamie, MD
HIV/AIDS , Implementation and Behavioral Science , Engagement in Care , Treatment Adherence
8/1/15
7/31/17
Sustainable approaches to care delivery in Uganda
Gabriel Chamie, MD
HIV/AIDS , Cancer/Oncology , Cardiovascular Disease , Chronic Respiratory Disease , Diet, Exercise, and Obesity , Implementation and Behavioral Science , Engagement in Care , Treatment Adherence
5/17/08
6/30/20
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda
Gabriel Chamie, MD
HIV/AIDS , Tuberculosis , Epidemiology and Surveillance
6/1/11
5/31/16
Structural Alcohol/HIV Risk Intervention in Gay Bar Patrons
Edwin Charlebois, PhD
HIV/AIDS , Risk Reduction and Prevention
9/1/11
8/31/13
Enhancing Care Engagement and Re-engagement
Edwin Charlebois, PhD
HIV/AIDS , Engagement in Care , Treatment Adherence
8/9/12
5/31/16
Structural Alcohol/HIV RIsk Intervention in Gay Bar Patrons
Edwin Charlebois, PhD
HIV/AIDS
6/1/13
8/31/14
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis
Edwin Charlebois, PhD
HIV/AIDS , Tuberculosis , Implementation and Behavioral Science
5/10/06
12/31/12
Getting to Zero: Advancing Retention and Re-Engagement in HIV Care Demonstration Project
Edwin Charlebois, PhD
HIV/AIDS , Engagement in Care , Treatment Adherence
12/1/15
11/30/18
Structural Alcohol Intervention to Reduce HIV Risk Behavior among Gay Bar Patrons
Edwin Charlebois, PhD
HIV/AIDS
9/1/12
8/31/14
Novel Evaluation Methods for Multi-Level/Combination HIV Prevention Interventions
Edwin Charlebois, PhD
HIV/AIDS
9/11/12
6/30/16
The Bixby Center for Global Reproductive Health - Annual Research Day Conference
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS
8/1/17
7/31/18
HPTN 084 Qualitative Substudy Funding
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Pharmacology and Drug Treatment
6/1/19
11/30/21
UZ-UCSF Clinical Trials Unit
Zvavahera Chirenje, MD, FRCOG
Sexually Transmitted Infections (STIs) , HIV/AIDS , Women's Health
9/20/10
11/30/10
HPTN 084 Development Funding
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS
7/1/17
11/30/18
HPTN 081 Protocol Funding - Development Costs
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Risk Reduction and Prevention
2/1/16
2/28/18
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Drug and Diagnostics Development , Women's Health , Labor and Delivery , Family Planning , Newborn and Infant Health , Risk Reduction and Prevention
6/1/14
11/30/17
HPTN 082 - Protocol Implementation Funding
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Drug and Diagnostics Development
2/1/16
7/31/19
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Pharmacology and Drug Treatment , Women's Health , Labor and Delivery , Family Planning , Newborn and Infant Health , Risk Reduction and Prevention
12/1/05
11/30/17
HVTN 120 Protocol Funding (PF)
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS
12/1/17
10/31/19
University of Zimbabwe-UCSF Clinical Trials Unit
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Women's Health , Health Systems Strengthening , Training and Capacity Building
1/1/07
11/30/13
UZ-UCSF Clinical Trials Unit
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Drug and Diagnostics Development , Women's Health , Family Planning , Pediatrics , Newborn and Infant Health
12/1/14
11/30/19
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Women's Health , Labor and Delivery , Family Planning , Pediatrics , Newborn and Infant Health
12/1/14
9/30/18
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Family Planning
6/1/14
7/31/16
HVTN 703/HPTN 081 Protocol Funding (PF)
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Drug and Diagnostics Development , Women's Health
12/1/15
11/30/18
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Drug and Diagnostics Development
6/1/14
11/30/15
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding
Zvavahera Chirenje, MD, FRCOG
Infectious Disease , HIV/AIDS , Drug and Diagnostics Development , Women's Health , Training International Scholars and Clinicians , Patient and Peer Education
2/1/15
8/31/17
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Women's Health , Labor and Delivery , Family Planning , Newborn and Infant Health , Risk Reduction and Prevention
6/1/14
11/30/14
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Women's Health , Labor and Delivery , Family Planning , Newborn and Infant Health , Risk Reduction and Prevention
6/1/14
11/30/14
UZ-UCSF Clinical Trials Unit
Zvavahera Chirenje, MD, FRCOG
Infectious Disease , HIV/AIDS , Pediatrics , Newborn and Infant Health , Risk Reduction and Prevention
12/10/13
11/30/20
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS , Drug and Diagnostics Development , Women's Health , Labor and Delivery , Family Planning , Newborn and Infant Health , Risk Reduction and Prevention
6/1/14
11/30/14
HVTN 107 Protocol Funding (PF)
Zvavahera Chirenje, MD, FRCOG
HIV/AIDS
12/1/16
11/30/18
Developing a Network-based HIV Prevention Intervention for MSM in China [I]
Kyung-Hee Choi, MPH, PhD
HIV/AIDS
4/1/06
3/31/07
Social/Sexual Networks & HIV Risk: Men of Color
Kyung-Hee Choi, MPH, PhD
HIV/AIDS
2/3/05
1/31/12
Influence of Stigma and Discrimination on HIV Risk among Men in China
Kyung-Hee Choi, MPH, PhD
HIV/AIDS , Risk Reduction and Prevention
9/7/09
5/31/15
Developing an HIV Prevention Intervention for HIV-Positive Men in China
Kyung-Hee Choi, MPH, PhD
HIV/AIDS , Implementation and Behavioral Science , Risk Reduction and Prevention
5/1/10
4/30/14
Integrating HIV/STI Prevention/Treatment in China
Kyung-Hee Choi, MPH, PhD
HIV/AIDS
9/9/05
8/31/10
An HIV Prevalence and Risk Behavior Survey of Male Sex Workers in Shanghai, China
Kyung-Hee Choi, MPH, PhD
HIV/AIDS
1/1/04
12/31/06
Developing a Network-based HIV Prevention Intervention for MSM in China [II]
Kyung-Hee Choi, MPH, PhD
HIV/AIDS
4/1/07
3/31/08
The Medical Consequences of Different Types of Heroin
Daniel Ciccarone, MD, MPH
Infectious Disease , HIV/AIDS , Substance Abuse
5/1/04
4/30/10
AETC National Resource Center / AIDS Education and Training Website
Susan Coffey, MD
HIV/AIDS , Training and Capacity Building
9/1/11
6/30/13
Adolescent Modules - AETC Web Site
Susan Coffey, MD
HIV/AIDS , Systematic Reviews and Guideline Development , Training and Capacity Building
3/17/05
9/17/05
Adolescent Modules - AETC Web Site (Cont.)
Susan Coffey, MD
HIV/AIDS , Systematic Reviews and Guideline Development , Training and Capacity Building
9/18/05
9/26/07
VA HIV Website
Susan Coffey, MD
HIV/AIDS
12/1/04
9/30/05
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey
Susan Coffey, MD
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training , Patient and Peer Education
9/30/15
8/31/20
Women, Children, and HIV Website (DBS)
Susan Coffey, MD
HIV/AIDS , Women's Health , Pediatrics , Newborn and Infant Health
4/1/07
3/31/08
Women, Children, and HIV Website
Susan Coffey, MD
HIV/AIDS , Women's Health , Patient and Peer Education
7/1/09
6/30/10
UMDNJ / WHO Dept. of HIV/AIDS "Development of an Annotated Inventory of PMTCT Tools and Guidelines"
Susan Coffey, MD
HIV/AIDS , Women's Health , Pediatrics , Newborn and Infant Health
3/1/07
6/30/07
UMDNJ / "Tanzania PMTCT Training Package"
Susan Coffey, MD
HIV/AIDS , Women's Health , Pediatrics , Training and Capacity Building
2/1/07
4/30/08
HIV Clinical Fellowship 2018 (Fellow May Baca)
Susan Coffey, MD
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
7/1/18
6/30/19
HIVMA Clinical Fellowship Program (Baca)
Susan Coffey, MD
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
7/1/18
6/30/19
VA HIV-HEP C Website Maintenance Services
Susan Coffey, MD
HIV/AIDS , Health Systems Strengthening , Training and Capacity Building , Patient and Peer Education
10/1/12
3/31/15
HIV-HEP C Website Maintenance Services
Susan Coffey, MD
Infectious Disease , HIV/AIDS , Patient and Peer Education
4/1/09
12/31/10
National Resource Center for HIV/AIDS Prevention among Adolescents (APNRC)
Susan Coffey, MD
HIV/AIDS
9/1/12
8/31/13
AIDS Education and Training Center (AETC) National Resource Center / Website
Susan Coffey, MD
HIV/AIDS , Opportunistic Infection , Training and Capacity Building , Training International Scholars and Clinicians , Residencies, Fellowships, and Postdoctoral Training , UCSF Professional Education , Patient and Peer Education
7/1/13
6/30/15
Women, Children, and HIV Website
Susan Coffey, MD
HIV/AIDS , Women's Health , Labor and Delivery , Family Planning , Pediatrics , Newborn and Infant Health , Training and Capacity Building
9/1/11
8/31/14
Agricultural intervention for food security and HIV health outcomes in Kenya
Craig Cohen, MD, MPH
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Health Economics and Effectiveness
5/7/15
4/30/20
STAR STI CTG
Craig Cohen, MD, MPH
HIV/AIDS , Women's Health , Labor and Delivery , Family Planning , Newborn and Infant Health
9/15/14
3/14/15
Impact of ART on Sexual Behaviors in Kisumu, Kenya
Craig Cohen, MD, MPH
HIV/AIDS
1/1/06
6/30/08
East Africa IEDEA Regional Consortium
Craig Cohen, MD, MPH
HIV/AIDS , Tuberculosis , Cancer/Oncology , Epidemiology and Surveillance
8/1/16
7/31/20
Travel Scholarships for Integration of Reproductive Health and HIV/AIDS Services Conference
Craig Cohen, MD, MPH
HIV/AIDS
1/1/12
12/31/12
Implementation and expansion of high quality, sustainable and comprehensive HIV prevention, care, and treatment to achieve 90-90-90 goals in Western Kenya
Craig Cohen, MD, MPH
HIV/AIDS , Implementation and Behavioral Science , Health Systems Strengthening , Training International Scholars and Clinicians
9/30/16
9/29/21
(PrEP) Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV1 Acquisition within HIV1 Discordant Couples
Craig Cohen, MD, MPH
HIV/AIDS
7/1/08
12/31/13
FACES Patient Care fund for research at Kenya
Craig Cohen, MD, MPH
HIV/AIDS , Infectious Disease , Sexually Transmitted Infections (STIs) , Cancer/Oncology , Diet, Exercise, and Obesity , Women's Health , Labor and Delivery , Family Planning , Pediatrics , Newborn and Infant Health , Adolescent Health , Health Economics and Effectiveness , Access or Barriers to Care , Stigma and Discrimination , Training and Capacity Building , Training International Scholars and Clinicians
7/1/19
6/30/20
Integrating Family Planning Services into HIV Care and Treatment in Nyanza Province, Kenya - Phase II
Craig Cohen, MD, MPH
HIV/AIDS
7/1/10
12/31/11
HIV/HSV Study Completion
Craig Cohen, MD, MPH
HIV/AIDS
7/1/09
3/31/12
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics
Craig Cohen, MD, MPH
Sexually Transmitted Infections (STIs) , HIV/AIDS , Women's Health
5/1/10
10/31/10
Integration of Family Planning into HIV Care and Treatment in Nyanza Province, Kenya
Craig Cohen, MD, MPH
HIV/AIDS , Implementation and Behavioral Science
11/12/09
6/30/14
Supporting the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in Kenya under PEPFAR
Craig Cohen, MD, MPH
HIV/AIDS , Implementation and Behavioral Science
7/1/10
9/29/16
Development of a Live Topical Microbicide for Women
Craig Cohen, MD, MPH
HIV/AIDS , Women's Health , Risk Reduction and Prevention
9/30/07
8/31/09
HIV Shedding from the Female Genital Tract
Craig Cohen, MD, MPH
HIV/AIDS , Women's Health
7/1/03
3/31/08
Consequences of an Intervention to Promote the Pasteurization of Breastmilk to Reduce the Transmission of HIV from Mothers to Their Breastfed Infants
Craig Cohen, MD, MPH
HIV/AIDS
5/1/10
4/30/12
Integrating Family Planning into HIV Care and Treatment
Craig Cohen, MD, MPH
HIV/AIDS
10/1/08
10/31/10
Process Evaluation and Toolkit Development in Support of Family Planning Integration into HIV Care & Treatment in Kenya
Craig Cohen, MD, MPH
HIV/AIDS , Women's Health , Family Planning , Newborn and Infant Health , Adolescent Health , Engagement in Care , Health Systems Strengthening
9/1/14
10/31/16
Phase III Randomized , Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV Discordant Couples HSV-2/HIV Transmission Study
Craig Cohen, MD, MPH
HIV/AIDS
11/1/03
9/30/08
Pilot Agricultural Intervention for Food Security and HIV Outcomes in Kenya
Craig Cohen, MD, MPH
HIV/AIDS
8/17/11
5/31/15
HIV Treatment for Research Subjects or By Researchers in Kenya
Craig Cohen, MD, MPH
HIV/AIDS
9/30/04
6/30/10
University of California Global Health Institute Program for Fellows and Scholars
Craig Cohen, MD, MPH
Sexually Transmitted Infections (STIs) , Zoonosis, Emerging Disease, and Drug Resistance , Neglected Tropical Diseases (NTDs) , HIV/AIDS , Opportunistic Infection , Tuberculosis , Malaria , Noncommunicable and/or Chronic Disease , Surgery and Anesthesia , Cancer/Oncology , Cardiovascular Disease , Chronic Respiratory Disease , Diabetes , Occupational and Environmental Disease , Diet, Exercise, and Obesity , Malnutrition, Micronutrients, Food Insecurity , Eye Disease and Blindness , Oral Health , Drug and Diagnostics Development , Immunology , Genetics , Pharmacology and Drug Treatment , Neurology and Mental Health , Dementia and Cognitive Impairment , Trauma and PTSD , Women's Health , Aging , Labor and Delivery , Family Planning , Pediatrics , Newborn and Infant Health , Adolescent Health , Health Economics and Effectiveness , Access or Barriers to Care , Immigration and Migration , Stigma and Discrimination , Smoking and Tobacco , Policy and Standards of Care , Systematic Reviews and Guideline Development , Epidemiology and Surveillance , Triangulation , Global Strategic Information , Implementation and Behavioral Science , Engagement in Care , Substance Abuse , Treatment Adherence , Health Systems Strengthening , Risk Reduction and Prevention , Residencies, Fellowships, and Postdoctoral Training
7/1/15
6/30/17
Accelerating Children's HIV/AIDS Treatment (ACT) initiative
Craig Cohen, MD, MPH
HIV/AIDS , Pediatrics , Access or Barriers to Care , Health Systems Strengthening , Training and Capacity Building
7/1/15
1/31/18
Stakeholder Meeting on the Integration of Reproductive Health and HIV/AIDS
Craig Cohen, MD, MPH
HIV/AIDS , Women's Health
9/29/11
12/31/12
Secretion of Virulence Factors by Mycobacterium tuberculosis
Infectious Disease , HIV/AIDS , Tuberculosis , Genetics
6/1/06
5/31/12
New Challenges in HIV Prevention for Gay Male Couples
Lynae Darbes, PhD
HIV/AIDS
8/1/10
7/31/15
HIV prevention for male couples in Africa
Lynae Darbes, PhD
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination , Risk Reduction and Prevention
6/19/15
1/31/16
Couples-Based HIV Prevention in South Africa
Lynae Darbes, PhD
HIV/AIDS
7/1/04
12/30/09
Implementing Partner: Understanding the HIV prevention needs of men who have sex with men (MSM) and their partners in Southern Africa: KwaZulu-Natal, South Africa and Namibia
Lynae Darbes, PhD
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination , Patient and Peer Education
6/1/15
7/31/17
Couples in Context: A Random Control Trial (RCT) of a Couples-Based HIV Prevention
Lynae Darbes, PhD
HIV/AIDS , Risk Reduction and Prevention
1/1/10
2/29/16
A Home-Based Couples Intervention to Enhance Prevention of Mother-to-Child-Transmission (PMTCT) and Family Health in Kenya
Lynae Darbes, PhD
HIV/AIDS , Women's Health , Engagement in Care , Treatment Adherence
5/1/14
3/31/16
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans
HIV/AIDS , Tuberculosis , Drug and Diagnostics Development
6/1/08
5/31/13
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV
HIV/AIDS , Opportunistic Infection , Tuberculosis , Chronic Respiratory Disease , Health Systems Strengthening , Training and Capacity Building , Training International Scholars and Clinicians
8/1/13
7/1/15
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans
HIV/AIDS
9/12/09
2/28/11
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans
HIV/AIDS
9/1/10
8/31/11
Prevention with Positives
Carol Dawson-Rose, RN, PhD, FAAN
HIV/AIDS
10/1/06
1/31/10
Combination HIV Prevention for the General Population of Adults and Youth, including Persons Living with HIV in Mozambique
Carol Dawson-Rose, RN, PhD, FAAN
HIV/AIDS , Implementation and Behavioral Science
2/21/11
7/31/14
Prevention for HIV-Positive Persons: An Intervention for HIV Care Providers
Carol Dawson-Rose, RN, PhD, FAAN
HIV/AIDS
9/30/01
9/29/06
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
Carol Dawson-Rose, RN, PhD, FAAN
HIV/AIDS
9/30/09
8/31/11
HIV prevention in Mozambique
Carol Dawson-Rose, RN, PhD, FAAN
HIV/AIDS , Implementation and Behavioral Science
7/1/14
6/30/20
T Regulatory Cells and T Cell Activation in HIV Disease
Steven Deeks, MD
HIV/AIDS , Immunology
9/1/02
2/28/07
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS
Steven Deeks, MD
HIV/AIDS
8/20/12
8/19/17
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research
Steven Deeks, MD
HIV/AIDS
12/15/99
12/15/09
UCSF/Ragon Collaboration on HIV "Elite" Controllers
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development , Immunology , Genetics
9/1/09
8/31/11
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response
Steven Deeks, MD
HIV/AIDS , Immunology
2/1/08
11/1/10
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
9/26/09
8/31/12
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients
Steven Deeks, MD
HIV/AIDS , Immunology , Women's Health
12/1/13
6/30/15
San Francisco National Clinical Trial Center, ESPIRIT
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
8/1/05
7/31/07
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node
Steven Deeks, MD
HIV/AIDS
6/15/15
5/31/20
Atripla Adherence and Resistance Relationships [I]
Steven Deeks, MD
HIV/AIDS , Treatment Adherence
10/1/07
8/31/10
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir
Steven Deeks, MD
HIV/AIDS , Immunology , Genetics
7/1/13
6/30/14
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation
Steven Deeks, MD
HIV/AIDS , Women's Health
12/1/13
5/31/15
Programming Long Term Durable HIV-1 Specific T cell Responses
Steven Deeks, MD
HIV/AIDS , Immunology
4/10/15
3/31/20
GS-US-382-3961: A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
2/1/17
1/31/20
Treatment Intensification for Drug-Resistant HIV
Steven Deeks, MD
HIV/AIDS
5/1/03
4/30/06
Measuring the Latent reservoir for HIV
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
1/1/17
12/31/19
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Steven Deeks, MD
HIV/AIDS
6/29/06
5/31/16
HIV Entry Inhibitors: A New Therapeutic Option
Steven Deeks, MD
HIV/AIDS , Immunology
7/1/06
6/30/11
Enfuvirtide Intensification for Multi-Drug Resistant HIV
Steven Deeks, MD
Zoonosis, Emerging Disease, and Drug Resistance , HIV/AIDS , Pharmacology and Drug Treatment
11/1/04
10/31/06
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
4/4/06
12/31/06
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients
Steven Deeks, MD
HIV/AIDS
4/1/11
6/30/12
Characterizing the Role of Immune Activation in HIV Persistence
Steven Deeks, MD
HIV/AIDS , Immunology
3/1/11
2/28/13
Deeks Order CNICS: June 2014-Aug 2016
Steven Deeks, MD
HIV/AIDS
10/1/15
9/30/20
Innate Effector Function and HIV-1 Control
Steven Deeks, MD
HIV/AIDS , Immunology
5/22/09
4/30/11
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
12/1/06
5/31/11
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease
Steven Deeks, MD
HIV/AIDS , Immunology
12/8/14
10/31/18
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
12/3/14
12/2/19
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation
Steven Deeks, MD
HIV/AIDS
10/1/11
9/30/13
Enhancing Control of HIV by Inhibiting TRAIL
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development , Immunology
7/2/13
6/30/18
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296
Steven Deeks, MD
HIV/AIDS , Noncommunicable and/or Chronic Disease , Pharmacology and Drug Treatment
6/1/12
5/31/13
HIV Specific T-Cell Responses in Rectal Mucosa
Steven Deeks, MD
HIV/AIDS
2/1/08
1/31/14
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes
Steven Deeks, MD
HIV/AIDS
8/15/13
7/31/15
Treating HIV-infected Elite Controllers as a Model of HIV Remission
Steven Deeks, MD
HIV/AIDS
7/9/10
7/8/13
Elite Controllers
Steven Deeks, MD
HIV/AIDS , Immunology , Genetics
11/1/07
10/31/08
Impact of HIV-Associated Inflammation on Disease
Steven Deeks, MD
HIV/AIDS
6/21/12
5/31/17
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
11/1/14
10/31/19
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation
Steven Deeks, MD
HIV/AIDS
9/1/10
8/31/12
Epigenetic Regulation of HIV Latency
Steven Deeks, MD
HIV/AIDS
7/1/10
2/28/15
Atripla Adherence and Resistance Relationships [II]
Steven Deeks, MD
HIV/AIDS , Treatment Adherence
1/24/08
8/31/10
Identifying and Targeting HIV Persistence in T Cell Subsets during ART
Steven Deeks, MD
HIV/AIDS
6/1/13
5/31/14
Combination immune checkpoint blocker inhibition to eliminate HIV latency
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
7/1/15
3/31/20
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
12/9/03
3/31/05
Delaney AIDS Research Enterprise to Cure HIV
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
7/14/16
6/30/21
HIV Controllers: A Potential Model for HIV Eradication
Steven Deeks, MD
HIV/AIDS , Immunology
7/1/06
6/30/07
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir
Steven Deeks, MD
HIV/AIDS
5/1/07
4/30/12
DARE: Delaney AIDS Research Enterprise to Find a Cure
Steven Deeks, MD
HIV/AIDS
7/8/11
6/30/17
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT
Steven Deeks, MD
HIV/AIDS
12/1/06
5/31/11
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
8/23/02
8/23/04
Short-Term Disulfiram Administration to Reverse Latent HIV Infection
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
9/1/12
8/31/13
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia
Joseph Derisi, PhD
Infectious Disease , Opportunistic Infection
9/1/14
5/31/19
Interactions Between HIV and Malaria in African Children
Grant Dorsey, MD
HIV/AIDS , Malaria
8/1/06
7/31/09
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients
Maria Ekstrand, PhD
HIV/AIDS , Drug and Diagnostics Development , Treatment Adherence
9/23/16
7/31/21
Examining ART Adherence Issues in Bangalore, India
Maria Ekstrand, PhD
HIV/AIDS
4/9/03
7/3/07
Enhancing HIV treatment adherence in South India: The Chetana study
Maria Ekstrand, PhD
HIV/AIDS , Women's Health , Stigma and Discrimination , Implementation and Behavioral Science , Treatment Adherence
7/1/16
6/30/18
Improving Mental Health through Integration with Primary Care in Rural Karnataka
Maria Ekstrand, PhD
HIV/AIDS , Neurology and Mental Health , Stigma and Discrimination
7/6/14
4/30/20
Reducing AIDS stigma among health professionals in South India
Maria Ekstrand, PhD
HIV/AIDS , Women's Health , Access or Barriers to Care , Stigma and Discrimination , Treatment Adherence
7/1/16
6/30/19
Reducing AIDS stigma among health professionals in South India
Maria Ekstrand, PhD
HIV/AIDS
7/15/13
6/30/18
Asha HIV Health Promotion Intervention
Maria Ekstrand, PhD
HIV/AIDS
9/18/08
6/30/12
AIDS Stigma and Gender: Health Consequences in Urban India
Maria Ekstrand, PhD
HIV/AIDS
6/1/03
5/31/09
AshaCare and Nutrition Program for Rural Indian Women Living with AIDS and Children
Maria Ekstrand, PhD
HIV/AIDS , Women's Health
7/23/13
3/31/18
Enhancing HIV Treatment Adherence in South India: The Chetana study
Maria Ekstrand, PhD
HIV/AIDS , Implementation and Behavioral Science , Treatment Adherence
9/9/11
6/30/16
AshaCare & Nutrition Program for Rural Indian Women Living with AIDS and Children
Maria Ekstrand, PhD
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Women's Health , Pediatrics
1/1/17
3/31/19
Context and Correlates of Health Behaviors in South India
Maria Ekstrand, PhD
HIV/AIDS , Epidemiology and Surveillance , Implementation and Behavioral Science , Substance Abuse
9/30/06
8/31/13
Homeless Female Offenders Returning to the Community: Improving Hopeful Futures
Maria Ekstrand, PhD
HIV/AIDS , Women's Health , Engagement in Care , Treatment Adherence , Health Systems Strengthening
1/1/17
5/31/18
Examining ART Adherence Issues in Bangalore, India
Maria Ekstrand, PhD
HIV/AIDS , Treatment Adherence
7/4/07
5/31/12
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV
HIV/AIDS , Tuberculosis
7/1/11
6/30/13
Culture-Based Prediction of Adolescent HIV Risk Behavior
HIV/AIDS , Adolescent Health , Risk Reduction and Prevention
8/15/07
6/30/13
The Immune Response to Acute Perinatal HIV Infection
Margaret Feeney, MD
HIV/AIDS
10/1/09
12/31/11
Analysis of HIV-Specific Lymphocytes in Infants Using Single-Cell Microtools
Margaret Feeney, MD
HIV/AIDS
10/1/09
9/30/13
The Impact of CD8 T Cells on Viral Control and Evolution in HIV-Infected Infants
Margaret Feeney, MD
HIV/AIDS
10/1/09
1/31/13
HIV/AIDS Clinical Care Training Program for Japanese Physicians
Mitchell Feldman, MD
HIV/AIDS , Training and Capacity Building
11/1/04
3/31/13
Japanese Health Professionals HIV/AIDS Training Program
Mitchell Feldman, MD
HIV/AIDS , Training International Scholars and Clinicians
4/1/13
3/31/19
International Medical Program for AIDS Clinical Training
Mitchell Feldman, MD
HIV/AIDS , Training International Scholars and Clinicians
7/1/14
6/30/20
Family Services Network - Ryan White HIV/AIDS Program
Monica Gandhi, MD, MPH
HIV/AIDS , Patient and Peer Education
7/1/15
6/30/20
Development of a point of care urine tenofovir immunoassay to distinguish adherence versus resistance-based HIV treatment failure
Monica Gandhi, MD, MPH
HIV/AIDS , Treatment Adherence
4/16/19
3/31/20
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria
Monica Gandhi, MD, MPH
HIV/AIDS , Neurology and Mental Health , Dementia and Cognitive Impairment
4/1/19
1/31/20
HIV Clinical Fellowship
Monica Gandhi, MD, MPH
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
9/1/17
8/31/18
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials
Monica Gandhi, MD, MPH
HIV/AIDS , Women's Health , Newborn and Infant Health , Treatment Adherence
9/30/15
7/31/19
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare
Monica Gandhi, MD, MPH
HIV/AIDS
8/1/17
7/31/20
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM
Monica Gandhi, MD, MPH
HIV/AIDS , Treatment Adherence
7/1/17
5/31/19
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials
Monica Gandhi, MD, MPH
HIV/AIDS
12/15/11
11/30/16
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence
Monica Gandhi, MD, MPH
HIV/AIDS , Treatment Adherence
1/1/16
12/31/20
AIDS Clinical Trials Group
Monica Gandhi, MD, MPH
HIV/AIDS
12/1/15
11/30/18
Positive Health Access to Services and Treatment (PHAST)
Monica Gandhi, MD, MPH
HIV/AIDS , Implementation and Behavioral Science , Engagement in Care , Treatment Adherence
7/22/15
7/31/16
Hair measures to assess adherence and explain outcomes in an HIV clinical trial
Monica Gandhi, MD, MPH
HIV/AIDS , Treatment Adherence
3/5/14
2/28/17
Assessing Antiretroviral Exposure in Diverse Populations
Monica Gandhi, MD, MPH
HIV/AIDS , Pharmacology and Drug Treatment
9/15/05
7/31/12
Herpesviral Gene Expression in Kaposi's Sarcoma
HIV/AIDS , Cancer/Oncology , Genetics
9/1/01
8/31/07
Evaluation of Haiti Quality Improvement of HIV Care
HIV/AIDS , Implementation and Behavioral Science
9/1/15
3/31/16
IeDEA Consortium East Africa data center
HIV/AIDS , Epidemiology and Surveillance , Implementation and Behavioral Science
7/1/14
6/30/20
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa
HIV/AIDS , Pharmacology and Drug Treatment
9/25/09
7/31/14
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R)
HIV/AIDS , Engagement in Care , Treatment Adherence , Health Systems Strengthening
7/24/14
10/31/19
Evaluation of Haiti Quality Improvement of HIV Care
HIV/AIDS , Implementation and Behavioral Science , Health Systems Strengthening
12/1/14
11/30/19
Quality Improvement Evaluation Center (Q-IEC)
HIV/AIDS
3/1/16
9/29/17
Geng Work Order RTI Health Solutions (Services for RTI/ViiV)
HIV/AIDS
9/1/16
12/31/16
Geng's work Order fee for Service Agreement / BMS MI A1424-562
HIV/AIDS
1/1/16
6/30/16
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS
HIV/AIDS , Implementation and Behavioral Science , Engagement in Care
9/1/11
8/31/16
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039)
HIV/AIDS , Epidemiology and Surveillance
9/1/16
8/30/21
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS
HIV/AIDS , Epidemiology and Surveillance
9/1/16
8/31/20
Tenofovir Kidney Toxicity Study
HIV/AIDS , Pharmacology and Drug Treatment
4/30/09
12/31/15
National HIV Training and Technical Cooperative Agreements-Focus Area: HIV/AIDS Medical Homes
Ronald Goldschmidt, MD
HIV/AIDS , Noncommunicable and/or Chronic Disease , Training and Capacity Building
9/1/11
7/30/13
The New York Pepline
Ronald Goldschmidt, MD
HIV/AIDS , Systematic Reviews and Guideline Development , Training and Capacity Building
6/1/10
9/30/16
National HIV/AIDS Clinicians' Consultation Center
Ronald Goldschmidt, MD
HIV/AIDS
9/1/03
8/31/06
Lutheran MC US-Caribbean HIV/AIDS Twinning Initiative
Ronald Goldschmidt, MD
HIV/AIDS , Health Systems Strengthening , Training and Capacity Building
4/1/04
8/31/07
The New York PEPline
Ronald Goldschmidt, MD
HIV/AIDS , UCSF Professional Education , Patient and Peer Education
7/1/08
6/30/10
National HIV/AIDS Clinicians' Consultation Center
Ronald Goldschmidt, MD
HIV/AIDS , Systematic Reviews and Guideline Development , Training and Capacity Building , UCSF Professional Education
9/1/11
8/31/16
UCSF - Ethiopia Fitun Warmline
Ronald Goldschmidt, MD
HIV/AIDS
1/1/09
10/31/12
Monitoring and Evaluating the State Legislative /Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-Care Settings
Ronald Goldschmidt, MD
HIV/AIDS , Systematic Reviews and Guideline Development
8/31/10
9/1/10
AIDS Education and Training Center, Telehealth Training Centers Program
Ronald Goldschmidt, MD
HIV/AIDS
9/1/11
6/30/15
Monitoring and Evaluating the State Legislative/Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-care Settings
Ronald Goldschmidt, MD
HIV/AIDS , Systematic Reviews and Guideline Development
9/30/08
9/29/09
AIDS Education and Training Center, National Clinician Consultation Center
Ronald Goldschmidt, MD
Infectious Disease , Sexually Transmitted Infections (STIs) , HIV/AIDS , Training International Scholars and Clinicians , Residencies, Fellowships, and Postdoctoral Training , UCSF Professional Education , Patient and Peer Education
7/1/16
6/30/20
Health Marketing Services for the CDC Act Against AIDS campaigns: HIV Screening Standard Care for Primary Care Physicians (HSSC) & One Test Two Lives (OTTL) for Obstetrical Providers
Ronald Goldschmidt, MD
HIV/AIDS
9/1/11
9/5/14
Sarlo Award for Excellence in Teaching for the AIDS Research Institute at UCSF
John Greenspan, BDS, PhD
HIV/AIDS , Training and Capacity Building
2/17/06
2/16/10
Teaching in Excellence Award for the AIDS Research Institute
John Greenspan, BDS, PhD
HIV/AIDS , Training and Capacity Building
2/16/10
2/16/12
Oral Manifestations of AIDS
John Greenspan, BDS, PhD
HIV/AIDS
5/1/00
4/30/07
For the Sarlo Teaching Award of the UCSF AIDS Research Institute
John Greenspan, BDS, PhD
HIV/AIDS , Training and Capacity Building
2/17/04
2/16/06
HIV-Related Oral Diseases Among Women in Harare
John Greenspan, BDS, PhD
HIV/AIDS , Women's Health
8/15/02
7/31/06
HIV Voluntary Testing and Counseling (VCT) and Linkage to Care in Uganda
Judith Hahn, PhD, MD
HIV/AIDS
9/13/07
7/31/13
Changes in Alcohol Consumption in HIV Positives in Uganda
Judith Hahn, PhD, MD
HIV/AIDS , Substance Abuse
7/15/10
3/31/15
Development and Pilot Testing of a Combination Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement among Fisherfolk in Uganda
Judith Hahn, PhD, MD
HIV/AIDS , Engagement in Care , Substance Abuse , Risk Reduction and Prevention
10/15/18
8/31/19
Impact of Heavy Alcohol Use on Pre-ART HIV Disease -- Uganda ARCH Cohort
Judith Hahn, PhD, MD
HIV/AIDS , Substance Abuse
9/20/11
8/31/16
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV, Hahn K24
Judith Hahn, PhD, MD
HIV/AIDS , Substance Abuse
9/1/16
8/31/19
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal
Judith Hahn, PhD, MD
HIV/AIDS , Tuberculosis , Substance Abuse
9/22/16
8/31/21
Training in Research Program on Alcohol Use by Persons-with-or-at-Risk for HIV
Judith Hahn, PhD, MD
HIV/AIDS , Substance Abuse
9/15/13
8/31/18
Measurement of Alcohol Use among HIV-Positives in Uganda
Judith Hahn, PhD, MD
HIV/AIDS
9/30/06
8/31/09
Integrating Alcohol Screening and Brief Intervention into HIV Care
Judith Hahn, PhD, MD
HIV/AIDS , Substance Abuse
8/28/13
8/27/18
Mobile technology to extend clinic-based counseling for HIV+s in Uganda
Judith Hahn, PhD, MD
HIV/AIDS , Substance Abuse
4/1/17
3/31/21
Regulatory T Cell Influence on Infant and Adult Immune Responses to HIV
HIV/AIDS
2/1/09
2/29/12
Oral Drug Treatment for Enhanced Immune Control over HIV Replication
HIV/AIDS , Pharmacology and Drug Treatment
3/30/11
5/1/12
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients
HIV/AIDS , Immunology
6/11/10
6/10/11
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients
HIV/AIDS , Noncommunicable and/or Chronic Disease
4/1/14
9/30/19
Virologic and Host Factors Contributing to HIV Control in Elite Controllers
HIV/AIDS
6/15/07
5/31/12
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals
HIV/AIDS , Cardiovascular Disease
7/1/12
6/30/15
Treating HIV-Infected Elite Controllers as a Model of HIV Remission
HIV/AIDS , Immunology
4/1/09
3/31/12
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir
HIV/AIDS
11/1/11
10/31/12
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study
HIV/AIDS , Pharmacology and Drug Treatment
6/23/12
12/22/15
Treating HIV-Infected Elite Controllers as a Model of HIV Remission
HIV/AIDS
5/17/10
4/25/14
International AIDS Research and Prevention
Diane Havlir, MD
HIV/AIDS
7/1/04
6/30/05
Heals Endowment Fund at the East Bay Community Foundation
Diane Havlir, MD
HIV/AIDS
11/1/13
10/31/16
AIDS Research and Services at SFGH
Diane Havlir, MD
HIV/AIDS
7/1/02
6/30/12
Sustainable East Africa Research in Community Health
Diane Havlir, MD
HIV/AIDS , Epidemiology and Surveillance , Engagement in Care , Treatment Adherence , Health Systems Strengthening , Risk Reduction and Prevention , Training International Scholars and Clinicians , Residencies, Fellowships, and Postdoctoral Training
5/13/13
6/30/20
AIDS Clinical Trials Group (ACTG) TTSG Services
Diane Havlir, MD
HIV/AIDS
6/1/11
5/31/12
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
Diane Havlir, MD
HIV/AIDS , Tuberculosis
9/1/08
2/28/10
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding)
Diane Havlir, MD
HIV/AIDS
12/1/14
11/30/18
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study
Diane Havlir, MD
HIV/AIDS , Cardiovascular Disease
3/1/16
2/28/18
Getting to Zero Coordinator/ SFPHF
Diane Havlir, MD
HIV/AIDS
7/1/16
6/30/19
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects
Diane Havlir, MD
HIV/AIDS , Tuberculosis
6/1/12
12/31/13
Task Order Supplement to A5267
Diane Havlir, MD
HIV/AIDS , Tuberculosis , Pharmacology and Drug Treatment
6/1/10
5/31/11
ACTG, AIDS Clinical Trial Research Group
Diane Havlir, MD
HIV/AIDS , Opportunistic Infection
1/1/14
11/30/20
UCSF HIV Clinical Trials Unit
Diane Havlir, MD
HIV/AIDS
1/1/07
5/30/14
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services
Diane Havlir, MD
HIV/AIDS , Tuberculosis
6/1/12
12/31/13
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates
Diane Havlir, MD
HIV/AIDS , Tuberculosis , Malaria , Cardiovascular Disease , Diabetes
9/19/16
8/31/17
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Diane Havlir, MD
HIV/AIDS
6/1/11
5/31/13
Clinical Studies of Interactions Between HIV and Malaria
Diane Havlir, MD
HIV/AIDS , Malaria
9/30/04
11/30/10
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298
Diane Havlir, MD
HIV/AIDS , Opportunistic Infection , Tuberculosis , Oral Health
6/1/12
12/31/13
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III)
Diane Havlir, MD
HIV/AIDS , Malaria
10/17/09
10/16/14
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
Diane Havlir, MD
HIV/AIDS , Tuberculosis
12/14/16
11/30/21
AIDS Clinical Trials Group (ACTG) Community Health Promoter
Diane Havlir, MD
HIV/AIDS
9/1/11
5/31/12
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257)
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
5/22/09
5/31/13
AIDS Clinical Trials Group; Protocol Funds
Diane Havlir, MD
HIV/AIDS
1/1/14
11/30/18
Training in HIV Translational Research
Diane Havlir, MD
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training , UCSF Professional Education
8/1/16
7/31/21
Adult AIDS Clinical Trials Unit (AACTU)
Diane Havlir, MD
HIV/AIDS
1/1/00
12/31/06
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s)
Diane Havlir, MD
HIV/AIDS
5/22/09
5/31/13
Therapeutic Strategies for HIV Disease
Diane Havlir, MD
HIV/AIDS
4/15/02
3/31/08
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load
Diane Havlir, MD
HIV/AIDS
6/1/11
5/31/12
Reducing Failure-to-Initiate ART: Streamlined ART Start
Diane Havlir, MD
HIV/AIDS , Access or Barriers to Care , Implementation and Behavioral Science , Engagement in Care
7/1/15
7/24/17
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A
Diane Havlir, MD
Infectious Disease , HIV/AIDS , Opportunistic Infection , Pharmacology and Drug Treatment
10/30/09
10/31/10
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
Diane Havlir, MD
HIV/AIDS , Tuberculosis
3/15/03
8/31/08
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262)
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
5/22/09
5/31/13
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s)
Diane Havlir, MD
HIV/AIDS , Cardiovascular Disease
8/8/14
4/30/20
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG)
Diane Havlir, MD
HIV/AIDS
12/1/18
11/30/20
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa
Diane Havlir, MD
HIV/AIDS , Malaria , Women's Health , Pediatrics
8/1/13
6/30/18
AIDS Research and Services at SF General Hospital
Diane Havlir, MD
HIV/AIDS , Engagement in Care , Treatment Adherence , Risk Reduction and Prevention
7/1/12
6/30/13
Therapeutic Strategies for HIV Disease
Diane Havlir, MD
HIV/AIDS
4/1/08
3/31/15
Task Order # 7: Supplement to SSS A5254
Diane Havlir, MD
HIV/AIDS , Opportunistic Infection , Oral Health
6/1/10
5/31/11
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
12/2/13
4/30/17
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites
Diane Havlir, MD
HIV/AIDS , Engagement in Care , Health Systems Strengthening , Training and Capacity Building
2/23/04
6/1/09
Neurological AIDS Research Consortium
Diane Havlir, MD
HIV/AIDS
12/1/11
9/30/12
Task Order # 9: Supplement to SSS A5272
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
6/1/10
5/31/11
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I)
Diane Havlir, MD
HIV/AIDS , Malaria
9/15/08
7/31/13
Productive and Latent HIV Infection in Gut Mucosal Reservoirs
Diane Havlir, MD
HIV/AIDS
12/1/11
8/31/13
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE)
Diane Havlir, MD
HIV/AIDS , Malaria , Pharmacology and Drug Treatment , Women's Health , Pediatrics , Newborn and Infant Health
7/1/16
6/30/20
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects
Diane Havlir, MD
HIV/AIDS , Tuberculosis
2/1/12
5/31/12
Training in HIV Primary Care - Uganda Clinicians
Diane Havlir, MD
HIV/AIDS , Training and Capacity Building
2/28/08
8/30/08
Sustainable East Africa Research in Community Health (SEARCH)
Diane Havlir, MD
HIV/AIDS , Infectious Disease , Noncommunicable and/or Chronic Disease , Health Economics and Effectiveness , Access or Barriers to Care
12/1/18
11/30/20
Task Order # 6: Supplement to SSS A5257
Diane Havlir, MD
HIV/AIDS
12/1/09
5/31/11
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
1/1/12
8/31/14
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position
Diane Havlir, MD
HIV/AIDS
11/9/09
8/31/11
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites
Diane Havlir, MD
HIV/AIDS , Pediatrics
2/23/09
2/22/12
Training in HIV Translational Research
Diane Havlir, MD
HIV/AIDS , Training and Capacity Building
9/5/05
7/31/10
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)
Diane Havlir, MD
HIV/AIDS , Adolescent Health
9/1/18
8/31/20
SEARCH/AIDS Clinical Trial Research Group
Diane Havlir, MD
HIV/AIDS
7/1/17
11/30/18
SFBay CTU
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
12/10/13
11/30/20
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)
Diane Havlir, MD
HIV/AIDS
7/1/12
6/30/15
UCSF HIV/AIDS Management Training Programs
Diane Havlir, MD
HIV/AIDS , Training and Capacity Building
9/1/05
10/31/05
Effect of Pitavastatin on Kidney Function in HIV-infected Persons
Diane Havlir, MD
HIV/AIDS , Cardiovascular Disease
7/1/16
6/30/18
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II)
Diane Havlir, MD
HIV/AIDS
7/20/09
7/19/14
HIV epidemiology and public health
Norman Hearst, MD, MPH
HIV/AIDS , Epidemiology and Surveillance
7/1/14
6/30/20
Developing an International Research Program in AIDS and Substance Abuse
Norman Hearst, MD, MPH
HIV/AIDS , Substance Abuse
7/1/11
6/30/12
Developing an International Research Program in AIDS and Substance Abuse [II]
Norman Hearst, MD, MPH
HIV/AIDS
7/1/13
6/30/15
Developing an International Research Program in AIDS and Substance Abuse [I]
Norman Hearst, MD, MPH
HIV/AIDS , Engagement in Care , Health Systems Strengthening
7/1/12
6/30/13
Improving and Evaluating HIV Response Implementation
Norman Hearst, MD, MPH
HIV/AIDS , Health Economics and Effectiveness , Policy and Standards of Care
11/15/10
5/31/11
Achieving durable retention in care for PMTCT Option B+: An intervention research
Jaco Homsy, MD, MPH
HIV/AIDS , Women's Health , Pediatrics , Implementation and Behavioral Science , Engagement in Care , Treatment Adherence
8/1/14
7/31/20
Posting at the Makerere University and Johns Hopkins University HIV Clinical Trials Unit in Kampala, Uganda
Jaco Homsy, MD, MPH
HIV/AIDS
2/1/11
1/31/13
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
Jaco Homsy, MD, MPH
HIV/AIDS , Women's Health
9/30/11
12/31/17
HQHIV1003203
Philip Hopewell, MD
HIV/AIDS , Tuberculosis
12/9/11
8/31/12
Effect of low dose methotrexate on endothelial function and inflammation in HIV
HIV/AIDS , Cardiovascular Disease
5/1/16
4/30/19
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
HIV/AIDS
9/26/13
7/31/18
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis
HIV/AIDS , Cardiovascular Disease
3/1/14
2/29/20
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV
HIV/AIDS , Immunology
4/1/15
8/31/20
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV
HIV/AIDS , Cardiovascular Disease
9/11/14
8/31/15
Effect of low dose methotrexate on endothelial function and inflammation in HIV
HIV/AIDS , Cardiovascular Disease
9/26/12
1/31/17
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans
HIV/AIDS , Cardiovascular Disease
9/1/16
6/30/20
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients
HIV/AIDS , Epidemiology and Surveillance
9/16/07
7/31/13
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
HIV/AIDS , Cardiovascular Disease , Pharmacology and Drug Treatment
9/25/08
6/30/15
Specimens Related to the MU-UCSF Research Collaboration
Laurence Huang, MD
HIV/AIDS
5/2/06
4/20/16
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS
Laurence Huang, MD
HIV/AIDS , Opportunistic Infection , Pharmacology and Drug Treatment
9/1/06
8/31/08
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll)
Laurence Huang, MD
HIV/AIDS
7/1/11
6/30/13
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
Laurence Huang, MD
HIV/AIDS
7/1/09
6/30/11
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study
Laurence Huang, MD
HIV/AIDS
9/25/09
7/31/16
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV
Laurence Huang, MD
HIV/AIDS , Chronic Respiratory Disease
8/1/10
7/31/16
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
Laurence Huang, MD
HIV/AIDS , Chronic Respiratory Disease
9/26/13
7/31/18
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases
Laurence Huang, MD
HIV/AIDS , Tuberculosis , Noncommunicable and/or Chronic Disease
1/1/14
12/31/19
PCP OPW Specimens
Laurence Huang, MD
Opportunistic Infection
6/5/03
9/30/04
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
Laurence Huang, MD
HIV/AIDS
9/28/07
12/31/14
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l))
Laurence Huang, MD
HIV/AIDS
9/28/07
6/30/12
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial)
Laurence Huang, MD
HIV/AIDS
7/1/13
6/30/15
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study
Laurence Huang, MD
HIV/AIDS , Chronic Respiratory Disease
7/1/15
4/30/20
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease
Laurence Huang, MD
HIV/AIDS , Chronic Respiratory Disease
7/1/09
6/30/11
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis
Laurence Huang, MD
HIV/AIDS , Tuberculosis
7/1/16
12/31/17
PCP OPW Specimens/Uganda Project Support
Laurence Huang, MD
Infectious Disease , HIV/AIDS , Opportunistic Infection
10/1/06
9/30/09
Evaluating a community-driven cervical cancer prevention model in western Kenya
Megan Huchko, MD
HIV/AIDS , Cancer/Oncology , Women's Health
9/19/14
8/31/19
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women
Megan Huchko, MD
HIV/AIDS , Cancer/Oncology
7/1/11
6/30/13
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order
Peter Hunt, MD
HIV/AIDS
6/1/11
5/31/12
Investigating Mechanisms of HIV Persistence in the Gut
Peter Hunt, MD
HIV/AIDS , Immunology
9/21/15
8/31/20
Valganciclovir to Reduce T Cell Activation in HIV Infection
Peter Hunt, MD
HIV/AIDS , Drug and Diagnostics Development , Immunology
4/18/06
3/29/08
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order
Peter Hunt, MD
HIV/AIDS
6/1/12
12/31/13
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans
Peter Hunt, MD
HIV/AIDS
8/1/12
7/31/14
Determinants of Functional Immune Defects in Treated HIV Infection and Aging
Peter Hunt, MD
HIV/AIDS , Aging
6/1/14
5/31/20
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
Peter Hunt, MD
HIV/AIDS
5/16/12
3/31/14
Intestinal MAIT Cells in HIV Infection
Peter Hunt, MD
HIV/AIDS
12/1/15
12/31/19
The Determinants of T Cell Activation in HIV Infection
Peter Hunt, MD
HIV/AIDS
4/15/05
3/31/10
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection
Peter Hunt, MD
HIV/AIDS
5/15/10
4/30/12
HIV-Specific T-cell Responses in Rectal Mucosa
Peter Hunt, MD
HIV/AIDS
9/1/10
8/31/12
HIV Pathogenesis and Immunity in Viremic Non-Progressors
Peter Hunt, MD
HIV/AIDS
8/1/10
7/31/12
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment
Peter Hunt, MD
HIV/AIDS , Cardiovascular Disease , Chronic Respiratory Disease , Aging
2/1/15
7/31/18
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans
Peter Hunt, MD
HIV/AIDS
8/1/08
1/31/13
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair)
Peter Hunt, MD
Infectious Disease , HIV/AIDS , Tuberculosis
1/1/14
11/30/20
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection
Peter Hunt, MD
HIV/AIDS
5/22/09
4/30/11
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment
Peter Hunt, MD
HIV/AIDS , Cancer/Oncology , Cardiovascular Disease , Aging
9/1/15
4/30/20
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV
Peter Hunt, MD
HIV/AIDS , Immunology
2/1/16
1/31/20
Mesalamine to Reduce T Cell Activation in HIV Infection
Peter Hunt, MD
HIV/AIDS , Drug and Diagnostics Development
4/1/10
3/31/13
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts
Vivek Jain, MD
HIV/AIDS , Pharmacology and Drug Treatment
8/26/11
4/30/17
Implementation science research on ART delivery in resource limited settings
Vivek Jain, MD
HIV/AIDS , Implementation and Behavioral Science
7/1/14
6/30/20
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts
Vivek Jain, MD
HIV/AIDS , Engagement in Care , Treatment Adherence , Health Systems Strengthening , Risk Reduction and Prevention
3/1/13
6/30/18
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations
Vivek Jain, MD
HIV/AIDS , Drug and Diagnostics Development
10/1/16
9/29/21
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART
HIV/AIDS
8/1/09
2/29/12
HIV Emergence of Drug Resistance
Zoonosis, Emerging Disease, and Drug Resistance , HIV/AIDS , Pharmacology and Drug Treatment
3/1/08
2/29/12
AIDS Malignancy Consortium (AMC)
Lawrence Kaplan, MD
HIV/AIDS , Opportunistic Infection , Cancer/Oncology
9/1/15
8/31/20
AIDS Malignancies Consortium
Lawrence Kaplan, MD
HIV/AIDS , Cancer/Oncology
9/1/10
8/31/15
Faith-based HIV Prevention for African American MSM
Susan Kegeles, PhD
HIV/AIDS
9/1/05
12/31/08
HIV Prevention for African American Down Low Men
Susan Kegeles, PhD
HIV/AIDS , Engagement in Care , Risk Reduction and Prevention , Patient and Peer Education
11/1/04
6/30/07
Multilevel HIV Prevention Intervention for Young African American Men
Susan Kegeles, PhD
HIV/AIDS , Risk Reduction and Prevention
9/1/12
7/31/17
HIV Translation Research for Young African American MSM
Susan Kegeles, PhD
HIV/AIDS , Access or Barriers to Care , Engagement in Care , Risk Reduction and Prevention
11/1/02
12/31/05
Traineeships in AIDS Prevention Studies
Susan Kegeles, PhD
HIV/AIDS , Neurology and Mental Health , Implementation and Behavioral Science , Training and Capacity Building , Residencies, Fellowships, and Postdoctoral Training
7/1/09
6/30/14
Web-Based, Structural HIV Prevention in MSM's Networks
Susan Kegeles, PhD
HIV/AIDS , Risk Reduction and Prevention
7/1/04
12/31/08
Moving a Research-Based Intervention into Practice
Susan Kegeles, PhD
HIV/AIDS , Implementation and Behavioral Science , Risk Reduction and Prevention
8/9/07
7/31/14
HIV Prevention for African American Down Low Men
Susan Kegeles, PhD
HIV/AIDS , Engagement in Care
7/1/07
6/30/08
Community Mobilization to Improve the HIV/AIDS Continuum of Care among Black Men
Susan Kegeles, PhD
HIV/AIDS , Risk Reduction and Prevention
9/12/13
7/31/18
NIMH Collaborative HIV/STD Prevention Trial
Susan Kegeles, PhD
HIV/AIDS
9/29/03
8/31/04
NIMH Collaborative HIV/STD Prevention Trial
Susan Kegeles, PhD
HIV/AIDS
9/1/05
8/31/06
Traineeships in AIDS Prevention Studies
Susan Kegeles, PhD
HIV/AIDS
7/1/04
6/30/09
Mpowerment Project Training Agreement
Susan Kegeles, PhD
HIV/AIDS , Adolescent Health , Training and Capacity Building , Patient and Peer Education
4/1/06
3/31/08
Mpowerment Project Training Agreement
Susan Kegeles, PhD
HIV/AIDS , Training and Capacity Building , Patient and Peer Education
11/2/05
11/4/05
Mpowerment Project Training Agreement
Susan Kegeles, PhD
HIV/AIDS , Adolescent Health , Risk Reduction and Prevention , Patient and Peer Education
9/21/04
9/23/04
Pilot of Culturally Tailored Mpowerment for HIV Prevention Among YMSM in Beirut
Susan Kegeles, PhD
HIV/AIDS , Adolescent Health , Access or Barriers to Care , Risk Reduction and Prevention , Patient and Peer Education
4/1/15
1/31/20
HIV Prevention for Transgender Individuals
Susan Kegeles, PhD
HIV/AIDS , Engagement in Care
8/1/05
9/29/09
Development of a Multilevel HIV Prevention for Latin American Men
Susan Kegeles, PhD
HIV/AIDS
9/8/10
5/31/14
NIMH Collaborative HIV/STD Prevention Trial
Susan Kegeles, PhD
HIV/AIDS , Implementation and Behavioral Science
9/1/06
8/31/07
Community Mobilization to Improve the HIV/AIDS Continuum of Care Among Black Men
Susan Kegeles, PhD
HIV/AIDS , Engagement in Care , Treatment Adherence , Risk Reduction and Prevention
8/1/16
7/31/20
HIV Prevention and Care for Peruvian MSM and Transgender Women
Susan Kegeles, PhD
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination
2/17/16
12/31/20
Addressing the Continuum of Prevention and Care among High-Risk Thai Men
Susan Kegeles, PhD
HIV/AIDS , Implementation and Behavioral Science , Risk Reduction and Prevention , Patient and Peer Education
7/1/19
6/30/20
Community-level HIV Prevention Intervention for Young Black Men
Susan Kegeles, PhD
HIV/AIDS , Implementation and Behavioral Science , Engagement in Care
9/1/06
8/31/12
Alcohol's impact on immunological and virological profiles in HIV patients
Mandana Khalili, MD
HIV/AIDS , Immunology , Substance Abuse
2/1/19
8/31/19
HBV/HIV Co-Infection Research Network
Mandana Khalili, MD
Sexually Transmitted Infections (STIs) , HIV/AIDS
9/23/13
8/31/19
Innate Immunity and Autophagy in Elite Controllers
HIV/AIDS
4/1/10
3/31/12
Studies of Ocular Complications of AIDS (SOCA)
HIV/AIDS , Eye Disease and Blindness
10/1/14
1/31/15
HIV Evaluation Activities with High-Risk, Underserved Populations in South Africa
Timothy Lane, PhD, MPH
HIV/AIDS , Implementation and Behavioral Science
9/30/11
3/30/18
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan
Timothy Lane, PhD, MPH
HIV/AIDS , Tuberculosis , Access or Barriers to Care , Stigma and Discrimination
9/30/16
9/29/18
Integrated Biological and Behavioral Surveillance (IBBS) with Population Size Estimation using Respondent Driven Sampling (RDS) among Men who have Sex with Men (MSM) in South Africa
Timothy Lane, PhD, MPH
HIV/AIDS , Epidemiology and Surveillance , Triangulation
12/1/16
9/1/18
Integrated Biological Behavioral Survey with Population Size Estimation using Respondent Driven Sampling among Men who have sex with Men
Timothy Lane, PhD, MPH
HIV/AIDS , Epidemiology and Surveillance , Triangulation
3/23/17
6/30/19
HIV Prevention among High-Risk Men in South Africa
Timothy Lane, PhD, MPH
HIV/AIDS
1/1/06
12/31/10
Health Empowerment for MSM in South Africa
Timothy Lane, PhD, MPH
HIV/AIDS
7/1/10
6/30/16
HIV Evaluation Activities with High Risk Underserved Populations in South Africa under PEPFAR
Timothy Lane, PhD, MPH
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination
9/29/16
12/1/18
Peer Navigation to Improve Engagement in Care for HIV-Positive MSM in South Africa
Timothy Lane, PhD, MPH
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination , Engagement in Care , Patient and Peer Education
7/1/16
12/31/19
HIV cure with CCR5 negative human IPS hematopoietic stem cells
HIV/AIDS , Drug and Diagnostics Development , Immunology
5/1/14
4/30/18
Identification of the CD8 Cell Anti-HIV Factor (CAF)
HIV/AIDS
1/1/12
8/31/15
Role of Innate Immunity in Controlling HIV Infection
HIV/AIDS
8/14/09
7/31/10
Identification of the CD8+ Cell Anti-HIV Factor (CAF)
HIV/AIDS , Immunology
12/21/09
12/20/12
Immunologic and Virologic Features of Early HIV Infection
HIV/AIDS , Risk Reduction and Prevention
7/1/02
6/30/08
UCSF AIDS Research Training Program
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
8/1/00
1/31/07
Role of Innate Immunity in Controlling HIV Infection
HIV/AIDS
7/1/03
12/31/06
Molecular Epidemiology of the Human Immunodeficiency Virus in Mexico
HIV/AIDS
7/1/08
12/31/09
Subcontract from UFL Prime: HIV/FIV-Cat-Model: A model to identify vaccine epitopes
HIV/AIDS
7/1/06
6/30/11
Identification of the CD8+ Cell Antiviral Factor (CAF)
HIV/AIDS
11/12/09
6/30/11
Role of Innate Immunity in Controlling HIV Infection
HIV/AIDS
3/1/07
8/31/08
HIV cure with CCR5 (-) human IPS hematopoietic stem cells
HIV/AIDS , Risk Reduction and Prevention
6/7/12
8/31/13
Role of Innate Immunity in Controlling HIV Infection
HIV/AIDS
9/15/07
2/28/12
JCF/Bransten Grant
HIV/AIDS
4/1/04
3/31/05
Protection from HIV Infection in Intravenous Drug Users
HIV/AIDS , Substance Abuse , Risk Reduction and Prevention
7/1/10
6/30/13
Does Shifting Gender Norms on the Community Level Lead to Increased HIV Services Uptake?
Sheri Lippman, PhD, MPH
HIV/AIDS , Stigma and Discrimination , Patient and Peer Education
7/1/15
6/30/19
Copy of Innovations in HIV testing to enhance care for young women and their partners
Sheri Lippman, PhD, MPH
HIV/AIDS , Access or Barriers to Care
3/4/15
2/28/19
Improving Health Outcomes for Women Living with HIV
Sheri Lippman, PhD, MPH
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination , Engagement in Care
1/20/17
12/31/20
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services
Sheri Lippman, PhD, MPH
HIV/AIDS , Systematic Reviews and Guideline Development
9/30/12
9/29/13
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services
Sheri Lippman, PhD, MPH
HIV/AIDS
9/30/11
11/30/12
Innovation Challenge CDC
Sheri Lippman, PhD, MPH
HIV/AIDS
10/1/18
9/29/19
Self-Conducted HIV Tests - Improving HIV Prevention in Key Populations
Sheri Lippman, PhD, MPH
HIV/AIDS , Access or Barriers to Care , Engagement in Care
8/1/14
5/31/17
Multilevel mechanisms of HIV acquisition in young South African women
Sheri Lippman, PhD, MPH
HIV/AIDS , Women's Health , Access or Barriers to Care , Implementation and Behavioral Science
4/22/16
1/31/21
Activating Treatment as Prevention through Community Mobilization in South Africa
Sheri Lippman, PhD, MPH
HIV/AIDS , Engagement in Care , Risk Reduction and Prevention
8/15/14
7/31/20
Toward Understanding Community Mobilization for HIV Prevention in the African Context
Sheri Lippman, PhD, MPH
HIV/AIDS , Risk Reduction and Prevention
6/18/10
4/30/13
Prevention Umbrella for MSM in the Americas
Sheri Lippman, PhD, MPH
HIV/AIDS , Risk Reduction and Prevention
8/1/11
7/31/13
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
4/18/11
8/17/13
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects
Anne Luetkemeyer, MD
HIV/AIDS
4/6/07
10/1/16
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
3/15/07
3/15/10
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1
Anne Luetkemeyer, MD
HIV/AIDS
7/11/13
7/11/17
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
12/18/13
5/17/17
GSK_201585: Phase III, randomized, multicenter, parallel-group, non inferiority, open-label study evaluating the efficacy, safety, & tolerability of switching to long-acting cabotegravir plus long acting rilpivirine from current INI,NNRTI, or PI-based ART
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
8/1/16
12/31/20
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s
Anne Luetkemeyer, MD
HIV/AIDS
6/1/09
6/30/13
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects
Anne Luetkemeyer, MD
HIV/AIDS , Tuberculosis
3/1/12
9/30/14
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia
Anne Luetkemeyer, MD
Infectious Disease , HIV/AIDS , Pharmacology and Drug Treatment
1/28/08
12/31/10
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
3/21/05
2/14/10
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV
Anne Luetkemeyer, MD
HIV/AIDS
11/28/11
3/31/15
M14-730 (EXPEDITION-2): A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection
Anne Luetkemeyer, MD
Infectious Disease , HIV/AIDS , Pharmacology and Drug Treatment
6/10/16
5/31/20
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
1/31/06
12/31/08
Gilead GS-US-236-0102
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
4/16/10
9/30/14
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men
Anne Luetkemeyer, MD
HIV/AIDS , Cancer/Oncology
3/22/12
3/21/15
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected
Anne Luetkemeyer, MD
HIV/AIDS
8/1/02
7/31/08
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255
Anne Luetkemeyer, MD
HIV/AIDS
6/1/12
12/31/13
Pfizer A4001027: Observational Phase Extension
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
5/13/08
6/30/12
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:)
Anne Luetkemeyer, MD
HIV/AIDS
7/1/10
6/30/12
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection
Anne Luetkemeyer, MD
Infectious Disease , HIV/AIDS , Pharmacology and Drug Treatment
6/18/15
10/31/16
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy
Anne Luetkemeyer, MD
Infectious Disease , HIV/AIDS , Pharmacology and Drug Treatment
9/1/14
7/31/19
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects
Anne Luetkemeyer, MD
HIV/AIDS
5/8/12
5/7/17
Epidemiological studies among drug users in Iran
Mohsen Malekinejad, MD, DrPH
HIV/AIDS , Epidemiology and Surveillance , Substance Abuse
7/1/14
6/30/20
Gilead Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
Jeffrey Martin, MD, MPH
HIV/AIDS
8/16/06
7/31/09
Uganda-UCSF Research Training Program in HIV-Associated Malignancies
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology
9/9/10
8/31/15
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology , Drug and Diagnostics Development
9/15/18
7/31/21
Cohort Study of Patients Receiving Long-Term Combination Therapy [II]
Jeffrey Martin, MD, MPH
HIV/AIDS , Drug and Diagnostics Development
12/12/00
6/30/05
Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Africa
Jeffrey Martin, MD, MPH
HIV/AIDS , Implementation and Behavioral Science , Treatment Adherence
7/1/10
12/31/15
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Jeffrey Martin, MD, MPH
HIV/AIDS
7/1/06
6/30/11
Implementation science to optimize HIV prevention in East Africa PEPFAR program
Jeffrey Martin, MD, MPH
HIV/AIDS
5/15/12
4/30/15
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer
Jeffrey Martin, MD, MPH
HIV/AIDS , Opportunistic Infection , Cancer/Oncology
9/17/14
8/31/20
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology , Drug and Diagnostics Development
8/17/16
7/31/19
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Jeffrey Martin, MD, MPH
HIV/AIDS
7/1/11
6/30/16
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology
12/10/07
6/30/11
East Africa IEDEA Regional Consortium
Jeffrey Martin, MD, MPH
HIV/AIDS
8/1/16
7/31/20
NAAccord (CHK-UP on HIV Supplement)
Jeffrey Martin, MD, MPH
HIV/AIDS , Noncommunicable and/or Chronic Disease , Cancer/Oncology , Cardiovascular Disease
9/22/09
8/31/12
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Jeffrey Martin, MD, MPH
HIV/AIDS
7/1/16
6/30/20
East Africa IEDEA Regional Consortium
Jeffrey Martin, MD, MPH
HIV/AIDS
8/1/11
7/31/16
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology
9/30/05
7/31/12
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology
12/19/06
7/31/09
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
Jeffrey Martin, MD, MPH
HIV/AIDS , Cancer/Oncology
4/3/07
11/12/12
Unsolicited R24 for the CFAR - Network of Integrated Clinical Sciences (CNICS)
Jeffrey Martin, MD, MPH
HIV/AIDS
9/1/11
8/31/16
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection
Toby Maurer, MD
HIV/AIDS , Cancer/Oncology
7/1/07
12/31/10
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya
Toby Maurer, MD
HIV/AIDS , Cancer/Oncology
9/1/15
8/31/19
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging
Toby Maurer, MD
HIV/AIDS , Cancer/Oncology , Pharmacology and Drug Treatment
8/20/14
8/19/17
Effects of Maraviroc on HIV-related Kaposi Sarcoma
Toby Maurer, MD
HIV/AIDS , Cancer/Oncology
7/1/11
9/30/17
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study
Toby Maurer, MD
Infectious Disease , HIV/AIDS , Women's Health
9/1/07
6/10/10
Disulfiram Interactions With HIV Medications: Clinical Implications
HIV/AIDS
9/15/08
5/17/13
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV
HIV/AIDS , Pharmacology and Drug Treatment , Substance Abuse
9/1/07
3/31/13
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection
HIV/AIDS
9/30/08
5/31/13
Opioids & HIV Medications: Interactions in Drug Abusers
HIV/AIDS
9/1/07
7/31/11
Timing of ART and homeostasis of the persistent HIV reservoir in the adult
Mike McCune, MD, PhD
HIV/AIDS , Immunology
2/4/15
1/31/21
HIV Proteomic Center for Host-Viral Responses Characterization
Mike McCune, MD, PhD
HIV/AIDS
11/4/08
5/31/12
Detection and Measurement of the HIV Reservoir
Mike McCune, MD, PhD
HIV/AIDS
10/1/11
9/30/12
Thymic Function in Adults With HIV-1 Disease
Mike McCune, MD, PhD
HIV/AIDS
4/1/06
3/31/10
Assessing Laboratory Correlates of Immune Protection
Mike McCune, MD, PhD
HIV/AIDS
3/1/06
12/31/08
HIV Proteomic Center for Host-Viral Responses Characterization
Mike McCune, MD, PhD
HIV/AIDS
11/4/08
5/31/12
Defining critical events in early HIV infection-effects of alcohol and early ART
Mike McCune, MD, PhD
HIV/AIDS , Immunology , Substance Abuse
7/1/15
6/30/17
Interruption of Maternal-Fetal Transmission of HIV
Mike McCune, MD, PhD
HIV/AIDS , Women's Health
9/5/09
8/31/14
HIV Effects on the Central Hematolymphoid System
Mike McCune, MD, PhD
HIV/AIDS
3/1/06
2/28/11
Exchange of samples- Placental Biopsies
Mike McCune, MD, PhD
HIV/AIDS , Women's Health
11/20/09
11/19/14
Early Antiretroviral Therapy and HIV Remission in Perinatal Infection
Mike McCune, MD, PhD
HIV/AIDS
5/1/14
4/30/20
Interferon-independent mechanisms of malaria restriction by helper T cells
Mike McCune, MD, PhD
HIV/AIDS , Malaria , Immunology
4/1/15
5/14/16
HIV Effects on the Central Hematolymphoid System
Mike McCune, MD, PhD
HIV/AIDS
4/9/10
2/28/12
Design of an Effective Vaccine against HIV: An Alternative Hypothesis
Mike McCune, MD, PhD
HIV/AIDS
10/1/08
5/31/10
Novel flow cytometry-based assay for HIV-infected cells
Mike McCune, MD, PhD
HIV/AIDS , Risk Reduction and Prevention
12/1/13
11/30/16
Design of an Effective Vaccine against HIV: An Alternative Hypothesis
Mike McCune, MD, PhD
HIV/AIDS
4/5/11
3/30/14
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1
Mike McCune, MD, PhD
HIV/AIDS , Immunology
12/15/01
12/31/04
The impact of TB co-infection on the reservoir of persistent HIV in vivo
Mike McCune, MD, PhD
HIV/AIDS , Tuberculosis , Immunology
9/1/15
4/30/20
Inflammation and HIV Persistence
Mike McCune, MD, PhD
HIV/AIDS
6/1/11
5/31/13
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings
John Metcalfe, MD
HIV/AIDS , Tuberculosis
3/4/11
2/29/16
Leadership and Operations, AIDS Clinical Trial Group
John Metcalfe, MD
HIV/AIDS
12/1/18
11/30/19
HIV Implementation Science Research Training Program
John Metcalfe, MD
HIV/AIDS , Training International Scholars and Clinicians
2/1/14
1/31/19
Development and Validation of a Diagnostic Tool for HIV Dementia
HIV/AIDS , Dementia and Cognitive Impairment
7/1/08
6/30/10
The Development of a Tool to Identify Peripheral Neuropathy and HIV Associated Dementia
HIV/AIDS , Dementia and Cognitive Impairment
7/1/09
5/31/11
The Development of a Tool to Identify Peripheral Neuropathy and HIV Associated Dementia
HIV/AIDS , Dementia and Cognitive Impairment
7/1/09
12/31/10
Treatment of HIV-Associated Cognitive Impairment
HIV/AIDS
9/19/11
8/2/13
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients
HIV/AIDS
9/30/11
7/7/13
New Combination Therapies for Early Cryptococcal Infection in HIV Infected Individuals: A Randomized Controlled Trial
HIV/AIDS
3/3/13
3/3/16
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa
Dominic Montagu, DrPH
HIV/AIDS , Tuberculosis , Health Economics and Effectiveness
10/1/03
4/30/05
AIDS Policy Research Center
Stephen Morin, PhD
HIV/AIDS , Health Economics and Effectiveness
1/1/08
12/31/11
Building Community Partnerships: Case Studies at Three HPTN Sites
Stephen Morin, PhD
HIV/AIDS , Health Systems Strengthening , Training International Scholars and Clinicians
9/1/05
5/31/06
Community-based VCT: Zimbabwe
Stephen Morin, PhD
HIV/AIDS
7/1/08
6/30/12
Center for AIDS Prevention Studies (CAPS)
Stephen Morin, PhD
HIV/AIDS , Risk Reduction and Prevention
9/24/01
8/31/06
Understanding the Acceptability of Pre-Exposure Prophylaxis (PrEP) to Prevent HIV among Men Who Have Sex with Men and Transgender People in California
Stephen Morin, PhD
HIV/AIDS , Risk Reduction and Prevention
5/1/11
8/31/11
AIDS Policy Research Center [I]
Stephen Morin, PhD
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training , Patient and Peer Education
4/1/09
9/30/12
Using ELI Data to Guide HIV Prevention in California
Stephen Morin, PhD
HIV/AIDS , Epidemiology and Surveillance
7/1/03
6/30/06
Center for AIDS Prevention Studies
Stephen Morin, PhD
HIV/AIDS
9/1/11
8/31/16
Community-Based HIV VCT: Zimbabwe
Stephen Morin, PhD
HIV/AIDS , Risk Reduction and Prevention
9/27/03
6/30/08
Center for AIDS Prevention Studies
Stephen Morin, PhD
HIV/AIDS
9/1/06
8/31/11
Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS
Stephen Morin, PhD
HIV/AIDS , Engagement in Care , Risk Reduction and Prevention
9/1/11
5/31/13
Health-Related Interventions for Persons Living with HIV
Stephen Morin, PhD
HIV/AIDS , Systematic Reviews and Guideline Development
8/18/03
7/31/06
HIV Testing, Prevention and Treatment in Health Centers Survey Tool
Stephen Morin, PhD
HIV/AIDS , Patient and Peer Education
5/1/04
5/30/05
AIDS Policy Research Center [II]
Stephen Morin, PhD
HIV/AIDS , Health Economics and Effectiveness , Access or Barriers to Care , Epidemiology and Surveillance , Implementation and Behavioral Science , Residencies, Fellowships, and Postdoctoral Training , Patient and Peer Education
1/1/09
6/30/10
Pediatric HIV/AIDS Cohort Study (PHACS)
Anna-Barbara Moscicki, MD
HIV/AIDS , Pediatrics , Adolescent Health
9/30/05
7/31/15
HPV Infections and Associated Morbidity in Children and Adolescents Perinatally Infected with HIV
Anna-Barbara Moscicki, MD
HIV/AIDS , Pediatrics , Epidemiology and Surveillance
7/1/08
1/20/12
A San Francisco Street Youth Cohort: At-Risk and HIV+
Anna-Barbara Moscicki, MD
HIV/AIDS , Adolescent Health , Engagement in Care , Risk Reduction and Prevention , Training and Capacity Building , Patient and Peer Education
3/3/06
2/28/13
Positive Affect Regulation for HIV Prevention in People with Mood Disorders
HIV/AIDS
12/2/10
6/30/14
A Positive Affect Intervention for Those Recently Diagnosed with HIV
HIV/AIDS , Implementation and Behavioral Science
7/18/08
5/31/14
XI International Conference on Human Retrovirology: HTLV
Edward Murphy, MD, MPH
HIV/AIDS , Transfusion Medicine
6/1/03
5/31/08
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites
Edward Murphy, MD, MPH
HIV/AIDS , Transfusion Medicine , Epidemiology and Surveillance , Training and Capacity Building
3/15/11
3/14/20
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites
Edward Murphy, MD, MPH
HIV/AIDS , Transfusion Medicine , Epidemiology and Surveillance
3/15/11
3/14/20
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Hub
Edward Murphy, MD, MPH
HIV/AIDS , Transfusion Medicine , Epidemiology and Surveillance
3/15/11
5/14/14
TO#2 Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites
Edward Murphy, MD, MPH
HIV/AIDS , Transfusion Medicine
11/1/11
9/30/19
Retrovirus Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites
Edward Murphy, MD, MPH
HIV/AIDS , Transfusion Medicine , Epidemiology and Surveillance
3/21/11
3/20/13
XV International Conference on Human Retrovirology: HTLV and Related Viruses
Edward Murphy, MD, MPH
HIV/AIDS , Infectious Disease , Transfusion Medicine
6/1/11
5/31/12
Conduct a systematic review of interventions to improve adherence and retention during TB and HIV co-treatment among people living with HIV
Payam Nahid, MD, MPH
HIV/AIDS , Tuberculosis , Systematic Reviews and Guideline Development , Treatment Adherence
1/29/19
11/15/19
The Collaborative HIV Prevention Research in Minority Communities Program
Torsten Neilands, PhD
HIV/AIDS
9/1/08
8/31/13
Collaborative HIV Prevention in Minority Communities
Torsten Neilands, PhD
HIV/AIDS
3/12/03
8/31/08
AIDS Stigma Among Health Professionals in Puerto Rico
Torsten Neilands, PhD
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination , Implementation and Behavioral Science
9/26/07
8/31/13
The Training Program for Scientists Conducting Research to Reduce HIV/AIDS Health Disparities
Torsten Neilands, PhD
HIV/AIDS , Risk Reduction and Prevention , Residencies, Fellowships, and Postdoctoral Training , UCSF Professional Education
9/1/13
8/31/18
Minority Communities HIV Prevention Research Training
Torsten Neilands, PhD
HIV/AIDS , Training and Capacity Building
8/1/03
5/31/09
A Randomized Trial to Prevent HIV Among Gay Couples
Torsten Neilands, PhD
HIV/AIDS , Risk Reduction and Prevention
9/20/16
7/31/20
The Training Program for Scientists Conducting Research to Reduce HIV/AIDS Health Disparities
Torsten Neilands, PhD
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
9/1/16
8/31/19
NIH Study of HIV/AIDS Stigma Reduction
Torsten Neilands, PhD
HIV/AIDS
4/1/14
3/31/16
Migration, Tourism and the HIV-drug use Syndemic in the Dominican Republic
Torsten Neilands, PhD
HIV/AIDS , Immigration and Migration , Epidemiology and Surveillance , Substance Abuse
12/4/13
5/31/18
Relationship Power and HIV Risk in Gay Male Couples
Torsten Neilands, PhD
HIV/AIDS , Implementation and Behavioral Science
6/21/10
4/30/15
Minority Populations Prevention Researcher Training
Torsten Neilands, PhD
HIV/AIDS , Risk Reduction and Prevention , Residencies, Fellowships, and Postdoctoral Training
7/15/14
6/30/20
Improving HAART Adherence in HIV+ Active Drug Users
HIV/AIDS
9/15/11
7/14/13
Chemoprohylaxis and HIV-Host Interactions
HIV/AIDS
4/9/07
3/31/13
Eliminating the Latent Reservoir through Self-Specific Antibodies
HIV/AIDS
11/1/11
10/31/12
Innate NKT Cells in HIV Infection
HIV/AIDS
7/1/06
4/30/07
Innate NKT Cells in HIV Infection
HIV/AIDS
7/1/12
9/30/13
Human Endogenous Retroelements in HIV Immunopathogenesis
HIV/AIDS
5/5/09
9/30/13
Cell Mediated Immunity in HIV-Infected Children
HIV/AIDS
7/1/06
12/31/11
Protective Immunity in HIV Highly Exposed but Uninfected Subjects
HIV/AIDS
3/15/10
2/28/13
Immunological Targeting of APOBEC Proteins to Cure HIV Infection
HIV/AIDS , Immunology
10/1/08
5/28/10
An Endogenous Retroelement Vaccine against HIV-1
HIV/AIDS
9/12/09
8/31/10
Protective immunity in HIV Highly Exposed but Uninfected Subjects
HIV/AIDS
7/1/10
6/30/11
Chemoprophylaxis and HIV-Host Interactions [II]
HIV/AIDS , Immunology
7/1/06
1/31/10
T Regulatory Cells in HIV Infection
HIV/AIDS
7/1/06
5/31/12
A Novel APOBEC-Based Vaccine Approach for HIV
HIV/AIDS
5/4/11
9/30/13
Viral Tropism and Immune Control in HIV
HIV/AIDS
7/1/06
6/30/09
Innate Natural Killer T (NKT) Cells in HIV Infection
HIV/AIDS
7/1/07
6/30/12
Enhanced HIV Prevention in the Republic of Uganda
HIV/AIDS , Implementation and Behavioral Science
9/30/11
9/29/12
Cambodia Integrated HIV and Drug Prevention Implementation Program
Kimberly Page, PhD, MPH
HIV/AIDS
5/15/12
4/30/16
Health Evaluation of the Young Man Study
Kimberly Page, PhD, MPH
HIV/AIDS , Epidemiology and Surveillance , Risk Reduction and Prevention
7/1/03
6/30/06
International Collaborative of Prospective Studies of HIV and Hepatitis in IDU
Kimberly Page, PhD, MPH
HIV/AIDS , Substance Abuse
5/15/11
4/30/15
Phase 1/2 Trial of Pharmacological HIV-1 Prevention
Kimberly Page, PhD, MPH
HIV/AIDS
9/15/03
6/30/07
Chemoprophylaxis and HIV-Host Interactions [I]
Kimberly Page, PhD, MPH
HIV/AIDS , Risk Reduction and Prevention
9/1/04
2/28/05
Safety and Pharmacokinetics of Tenofovir and Emtricitabine in HIV Negative Thai Women
Kimberly Page, PhD, MPH
HIV/AIDS , Women's Health , Risk Reduction and Prevention
8/7/06
7/31/07
Chemoprophylaxis for HIV Prevention in Peruvian Men
Kimberly Page, PhD, MPH
HIV/AIDS
8/15/05
1/31/10
Culture and HIV Prevention in Cambodia
Kimberly Page, PhD, MPH
HIV/AIDS , Implementation and Behavioral Science
1/1/09
6/30/12
Amphetamine-Type Stimulant (ATS) Use HIV among Young Female Sex and Entertainment Workers in Cambodia
Kimberly Page, PhD, MPH
HIV/AIDS
7/1/08
6/30/09
HPV testing of samples from the AIDS Malignancy Consortium
Joel Palefsky, MD
HIV/AIDS , Opportunistic Infection , Cancer/Oncology
10/1/15
9/30/16
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
Joel Palefsky, MD
HIV/AIDS , Infectious Disease , Sexually Transmitted Infections (STIs) , Cancer/Oncology
7/11/18
6/30/20
California Division Special Research Scholar Grant in HIV-Related Cancers
Joel Palefsky, MD
HIV/AIDS , Cancer/Oncology
8/31/03
8/30/08
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected
Joel Palefsky, MD
HIV/AIDS , Opportunistic Infection , Cancer/Oncology
7/9/15
7/8/20
HIV Facilitated Paracellular Penetration of HPV across Mucosal Epithelium
Joel Palefsky, MD
HIV/AIDS
7/1/08
12/31/10
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium
Joel Palefsky, MD
HIV/AIDS , Cancer/Oncology , Women's Health
9/1/06
7/31/10
HPV and AIDS Malignancies Clinical Trials Consortium (AMC)
Joel Palefsky, MD
HIV/AIDS , Cancer/Oncology
8/1/99
7/31/05
SMART Anal Dysplasia Sub-Study
Joel Palefsky, MD
HIV/AIDS , Opportunistic Infection , Cancer/Oncology
11/1/04
3/31/06
HPV and Cervix Neoplasia in a Large, Long Term HIV+ Cohort
Joel Palefsky, MD
HIV/AIDS , Aging
1/1/02
4/30/05
HPV Testing of Samples from the AIDS Malignancy Consortium
Joel Palefsky, MD
HIV/AIDS
9/1/10
8/31/15
Anal Dysplasia SCC Supplement for P30 Cancer Support Grant to Stimulate HIV/AIDS Cancer Research Projects NCI-designated Cancer Centers
Joel Palefsky, MD
HIV/AIDS , Infectious Disease , Cancer/Oncology
7/1/18
6/30/20
Women and Infants Transmission Study - Human Papillomavirus Protocol
Joel Palefsky, MD
Infectious Disease , HIV/AIDS , Cancer/Oncology , Women's Health
7/1/03
6/30/05
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men
Joel Palefsky, MD
HIV/AIDS , Cancer/Oncology
9/21/11
8/31/15
Incidence of HIV among Indian Men Who Have Sex with Men
Joel Palefsky, MD
HIV/AIDS , Epidemiology and Surveillance
9/19/11
8/31/15
Doris Duke Charitable Foundation International Clinical Research Fellowship Program
Joel Palefsky, MD
HIV/AIDS , Tuberculosis , Malaria , Cancer/Oncology , Cardiovascular Disease , Oral Health , Neurology and Mental Health , Women's Health , Pediatrics , Newborn and Infant Health , Immigration and Migration , Training and Capacity Building , Residencies, Fellowships, and Postdoctoral Training
1/1/07
6/30/09
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Joel Palefsky, MD
HIV/AIDS
6/1/12
12/31/13
Natural History of Anal Neoplasia in HIV-Infected Men
Joel Palefsky, MD
HIV/AIDS
9/30/97
7/31/04
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
Joel Palefsky, MD
Infectious Disease , HIV/AIDS , Cancer/Oncology
8/1/16
7/31/21
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men
Joel Palefsky, MD
Infectious Disease , HIV/AIDS , Cancer/Oncology
1/13/17
12/31/19
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries
Joel Palefsky, MD
HIV/AIDS , Cancer/Oncology , Women's Health
8/1/15
7/31/17
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia
Joel Palefsky, MD
Infectious Disease , HIV/AIDS , Cancer/Oncology
7/1/07
6/30/13
Cidofovir for Perianal Dysplasia in HIV Patients
Joel Palefsky, MD
HIV/AIDS , Cancer/Oncology
9/1/07
8/31/10
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium
Joel Palefsky, MD
HIV/AIDS , Opportunistic Infection , Cancer/Oncology
8/10/15
8/10/18
Anal HPV Infection and ASIL in HIV+ and HIV- Women
Joel Palefsky, MD
HIV/AIDS , Women's Health
5/22/01
4/30/08
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
Marion Peters, MD
HIV/AIDS , Infectious Disease
1/1/14
11/30/20
AIDS Clinical Trials Group (ACTG), TSG Committee Chair funding
Marion Peters, MD
HIV/AIDS
1/1/14
11/30/14
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants
Marion Peters, MD
Sexually Transmitted Infections (STIs) , HIV/AIDS , Women's Health
9/16/16
6/30/19
HIV Status and Reproductive Aging Affect Liver Fibrosis in HIV/HCV Infected Women
Marion Peters, MD
HIV/AIDS , Women's Health
3/15/10
2/28/13
AIDS Clinical Trials Group Network (ACTG)
Marion Peters, MD
HIV/AIDS
6/1/11
5/31/12
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers
Christopher Pilcher, MD
HIV/AIDS
9/7/12
6/30/17
The effects of alcohol on acute HIV associated neurocognitive disorders
Christopher Pilcher, MD
HIV/AIDS , Dementia and Cognitive Impairment , Substance Abuse
9/1/15
3/31/16
Host Factors Influencing HIV Viral Load and Infectivity in Semen
Christopher Pilcher, MD
HIV/AIDS , Risk Reduction and Prevention
7/25/12
5/31/17
HIV Incidence Testing using Multiple Biological Specimens
Christopher Pilcher, MD
HIV/AIDS
8/27/12
7/31/16
Targeting Acute HIV
Christopher Pilcher, MD
HIV/AIDS , Risk Reduction and Prevention
4/16/07
6/30/10
HIV Incidence Testing in Hair
Christopher Pilcher, MD
HIV/AIDS , Drug and Diagnostics Development , Treatment Adherence
11/1/09
4/30/11
HIV RNA and/or Antibody Confirmed Positive Plasma
Christopher Pilcher, MD
HIV/AIDS
11/4/11
11/3/16
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay
Christopher Pilcher, MD
HIV/AIDS , Drug and Diagnostics Development
8/20/13
3/19/15
Data Collected through the IAVI Early Infection Cohort Study
Christopher Pilcher, MD
HIV/AIDS
3/1/11
2/29/16
Development of Specimen Repository and Evaluation of Assays for Identification of Recent HIV Infection
Christopher Pilcher, MD
HIV/AIDS
4/1/11
12/31/14
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay
Christopher Pilcher, MD
HIV/AIDS , Drug and Diagnostics Development
7/1/13
12/31/14
HIV Molecular Surveillance
HIV/AIDS
5/1/12
12/31/13
Effects of CCR5-D32 Heterozygosity on the HIV-1 Reservoir
HIV/AIDS
2/1/13
1/31/14
Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients
HIV/AIDS
5/1/08
4/30/14
HIV/AIDS Primary Care Capacity in Nursing (PCC)
Carmen Portillo, RN, PhD, FAAN
HIV/AIDS , Training and Capacity Building , Residencies, Fellowships, and Postdoctoral Training , Patient and Peer Education
7/1/15
6/30/20
HIV/AIDS Nursing Care and Prevention
Carmen Portillo, RN, PhD, FAAN
HIV/AIDS
7/1/12
6/30/17
HIV/AIDS Nursing Care and Prevention
Carmen Portillo, RN, PhD, FAAN
HIV/AIDS , Training and Capacity Building
7/1/07
6/30/12
Positive Health: Advanced Nurse Practice Education
Carmen Portillo, RN, PhD, FAAN
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training , UCSF Professional Education
7/1/04
6/30/07
HIV/AIDS Primary Care Capacity in Nursing (PCC)
Carmen Portillo, RN, PhD, FAAN
HIV/AIDS , Training and Capacity Building
7/1/13
6/30/18
HIV/AIDS Collaborative Health Model for Nursing Education
Carmen Portillo, RN, PhD, FAAN
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
6/1/04
5/31/05
Central Nervous System HIV Translational Research Training Program
Richard Price, MD
HIV/AIDS , Neurology and Mental Health , Residencies, Fellowships, and Postdoctoral Training
6/1/10
5/31/15
HIV Proteomics Center for Host Viral Response Characterization
Richard Price, MD
HIV/AIDS
9/30/08
5/31/12
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Richard Price, MD
HIV/AIDS
3/1/09
5/31/15
The Neuropathobiology of Primary HIV-1 Infection
Richard Price, MD
HIV/AIDS , Neurology and Mental Health
4/1/10
3/31/12
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START
Richard Price, MD
HIV/AIDS
12/15/15
1/31/20
The Pathobiology of Primary HIV-1 Infection
Richard Price, MD
HIV/AIDS
11/26/10
1/31/15
CNS Immune / Inflammatory Biomarkers in HIV Controllers
Richard Price, MD